Summit therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Summit therapeutics Contact Number

Summit Therapeutics Crunchbase Company Profile & …

9 hours ago Crunchbase.com Show details

235 443 939Company Type For Profit. Contact Email [email protected] Phone Number +44 (0)1235 443 939. Summit Therapeutics is a clinical-stage drug discovery and development company. The company's new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.

Founded: Jul 01, 2007
Location: Abingdon, Oxfordshire

Category: Contact NumberShow more

Contact summittxinc.com

5 hours ago Summittxinc.com Show details

235 443 999Oxford, England Office (UK) 136a Eastern Avenue Milton Park Abingdon Oxfordshire OX14 4SB United Kingdom: [email protected]: Cambridge, England Office (UK)

Fax: +44 (0)1235 443 999
Investor Inquiries: [email protected]
General Inquiries: [email protected]
Phone: UK: +44 (0)1235 443 939US: +1 617 514 7149

Category: Contact SupportShow more

Summit Therapeutics Overview, News & Competitors

Just Now Zoominfo.com Show details

NEW YORK, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888 …

Employees: 79
Phone: 01235 443939
Location: Rosemary Ln, Cambridge, CB1 3LQ, Cambridgeshire

Category: Contact NumberShow more

SUMMIT THERAPEUTICS LLC NPI 1538591235

2 hours ago Healthprovidersdata.com Show details

(907) 232-7976SUMMIT THERAPEUTICS LLC NPI is 1538591235. The provider is registered as an organization entity type and is a single specialty group. The provider's authorized official is Michelle Joann Scott-weber . The authorized official title is Member and has the following contact phone number (907) 232-7976. The enumeration date for this NPI number is 8

Location: 1700 E BOGARD RD STE A101, WASILLA, 99654, AK
Phone: 090-7232-7976

Category: Contact NumberShow more

SUMMIT THERAPEUTICS, LLC, NPI 1558826693 Behavior

7 hours ago Npiprofile.com Show details

Summit Therapeutics, Llc is a provider established in Dawsonville, Georgia specializing in behavior analyst. The NPI number of Summit Therapeutics, Llc is 1558826693 and was assigned on February 2019. The practitioner's primary taxonomy code is 103K00000X.

NPI: 1558826693
Provider Mailing Address: 208 SUMMITRAIL LN DAWSONVILLE, GA 30534
Provider Location Address: 208 SUMMITRAIL LN DAWSONVILLE, GA 30534
Location: 208 SUMMITRAIL LN, DAWSONVILLE, 30534, GA

Category: Contact NumberShow more

Summit Therapeutics Company Profile Office Locations

6 hours ago Craft.co Show details

888-476-6529NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Category: Contact NumberShow more

Advancing Innovative Therapies Summit Plc

8 hours ago Summittxinc.com Show details

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021 News / 03 Nov 2021 Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory & Clinical Research Executive Dr. Urte Gayko News / 08 Oct 2021

Category: Contact NumberShow more

Summit Therapeutics Inc. in Cambridge, MA Company Info

7 hours ago Bizapedia.com Show details

Summit Therapeutics Inc. is a Massachusetts Foreign Corporation filed On April 15, 2014. The company's File Number is listed as 001133812. The Registered Agent on file for this company is C T Corporation System and is located at 155 Federal St., Suite 700, Boston, MA 02110.

Location: MA

Category: Contact NumberShow more

Summit Therapeutics Inc. Boston MA, Cambridge MA, and

7 hours ago Bizapedia.com Show details

SUMMIT THERAPEUTICS INC. MASSACHUSETTS FOREIGN CORPORATION: WRITE REVIEW: Address: 1 Broadway, 14th Floor Cambridge, MA 02142: Registered Agent: C T Corporation System: Filing Date: April 15, 2014: File Number: 001133812: Contact Us About The Company Profile For Summit Therapeutics Inc.

Category: Contact NumberShow more

Careers summittxinc.com

6 hours ago Summittxinc.com Show details

Where you’re not just a number? Come and join our team. You don’t have to just take our word for it; we asked our people what they think about working at Summit and this is what they told us…. 100% of our people say they are proud to work at Summit. 100% of our people say their role at …

Category: Contact NumberShow more

Investor Center summittxinc.com

4 hours ago Summittxinc.com Show details

Investor Center. News. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021. VIEW NEWS. Summit Therapeutics Bolsters Its Board of Directors with Seasoned Regulatory …

Category: Contact NumberShow more

Summit Therapeutics Massage Therapy in Centennial, Colorado

7 hours ago Summittherapeuticsdenver.com Show details

Summit Therapeutics stands apart because we offer an integrative approach to meeting your bodywork needs. Your body is a complex system, different than anyone else’s. Your unique mechanics, pain patterns, and lifestyle all impact what your appointments will look like, and which modalities will work best for …

Category: Contact NumberShow more

Summit Therapeutic Services

5 hours ago Stshelps.com Show details

At Summit we strive to be our best selves for ourselves and for the world around us. We have a mission to support those seeking help and lift up those who struggle to find their footing. Following a training model has allowed a collective with years of experience and higher education in therapeutic behavioral services to empower and assist in

Category: Contact NumberShow more

(SMMT) Alert: Did You Lose Money on Your Summit

1 hours ago Finance.yahoo.com Show details

SAN DIEGO, Oct. 2, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws …

Category: Contact NumberShow more

Summit Therapeutics : Provides Update on RiCoDIFy Trials

5 hours ago Marketscreener.com Show details

Summit Therapeutics Provides Update on Ri-CoDIFy Trials. Cambridge, Massachusetts - Based on a thorough review of the design and enrollment status of two ongoing blinded Phase III Ri-CoDIFy trials, Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it will combine its two blinded pivotal Phase III clinical trials evaluating ridinilazole versus vancomycin into a single study.

Category: Contact NumberShow more

SUMMIT THERAPEUTICS INC. : Change in Directors or

6 hours ago Marketscreener.com Show details

Effective on November 3, 2021, the board of directors (the "Board") of Summit Therapeutics Inc. (the "Company") unanimously approved (i) the election of Urte Gayko as a director of the Company, to occupy a newly created seat on the Board and (ii) the appointment of Dr. Gayko to serve on the Nominating and Corporate Governance Committee.

Category: Contact NumberShow more

Our Collaborations summittxinc.com

6 hours ago Summittxinc.com Show details

Our Collaborations. Our Collaborations. Summit seeks to maximise the value of its pipeline, which includes entering into collaborations with academic and government institutions and biotech and pharmaceutical companies. For more information, or to inquire about in- or out-licensing opportunities, please contact [email protected] CDI Programme

Category: Contact NumberShow more

SUMMIT THERAPEUTICS LIMITED Filing history (free

Just Now Find-and-update.company-information.service.gov.uk Show details

303 1234 500SUMMIT THERAPEUTICS LIMITED. Company number 05197494. Follow Registers for SUMMIT THERAPEUTICS LIMITED (05197494) More for SUMMIT THERAPEUTICS LIMITED (05197494) This document is not available online but it may be possible to order a copy from the Contact Centre. Telephone +44(0)303 1234 500.

Category: Contact NumberShow more

Summit Therapeutics Inc Reports Financial Results and

7 hours ago Finance.yahoo.com Show details

Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on

Category: Contact NumberShow more

SUMMIT THERAPEUTICS LIMITED More (free company

Just Now Find-and-update.company-information.service.gov.uk Show details

Company number 05197494 Follow this company File for this company Company Overview for SUMMIT THERAPEUTICS LIMITED (05197494)

Category: Contact NumberShow more

Summit Therapeutics Provides Update on RiCoDIFy Trials

7 hours ago Globenewswire.com Show details

Summit Therapeutics Provides Update on Ri-CoDIFy Trials. under contract number HHSO100201700014C. About Summit Therapeutics Contact Summit Investor Relations.

Category: Contact NumberShow more

SUMMIT THERAPEUTICS LIMITED Overview (free company

5 hours ago Find-and-update.company-information.service.gov.uk Show details

for SUMMIT THERAPEUTICS LIMITED (05197494) More. for SUMMIT THERAPEUTICS LIMITED (05197494) Registered office address. 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4SB. Company status. Active. Company type. Private limited Company.

Category: Contact NumberShow more

SUMMIT THERAPEUTIC SERVICES LinkedIn

Just Now Linkedin.com Show details

SUMMIT THERAPEUTIC SERVICES. 27 followers. 2mo. Report this post. Summit Therapeutic is hiring in the San Jose and Sacramento areas. San Jose locations include San Jose, Hollister and Morgan Hill

Category: Contact NumberShow more

Summit Therapeutics : set to join Russell 3000® Index

1 hours ago Marketscreener.com Show details

Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions posted by FTSE Russell.. Annual Russell indexes reconstitution captures …

Category: Contact NumberShow more

Shareworks Login

5 hours ago Summittherapeutics.solium.com Show details

Open Account Contact Us Sign in to Shareworks using: Username, or account number Recommended Username, or account number Recommended. Email Address. Employee Number (Participant Only) * Username, or account number: * Password: Forgot your account? Forgot your password?

Category: Contact NumberShow more

(MRTX) Alert: Did You Lose Money on Your Mirati

1 hours ago Finance.yahoo.com Show details

SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Mirati Therapeutics, Inc. (NASDAQ: MRTX) for violations of

Category: Contact NumberShow more

Summit Therapeutics Inc Reports Financial Results and

8 hours ago Globenewswire.com Show details

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021. Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE

Category: Contact NumberShow more

Summit Therapeutics Shares Outstanding 20152021 SMMT

5 hours ago Macrotrends.net Show details

Summit Therapeutics shares outstanding from 2015 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Category: Contact NumberShow more

Statement of Changes in Beneficial Ownership (4)

2 hours ago Ih.advfn.com Show details

5.40. Statement of Changes in Beneficial Ownership (4) October 12 2021 - 08:41AM. Edgar (US Regulatory) FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1 (b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL

Category: Contact NumberShow more

Current Report Filing (8k)

1 hours ago Ih.advfn.com Show details

Results of Operations and Financial Condition. On November 15, 2021, Summit Therapeutics Inc. announced its financial results and operational highlights for the three and nine months ended September 30, 2021. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Category: Contact NumberShow more

Summit Therapeutics Provides Update on RiCoDIFy Trials

Just Now Benzinga.com Show details

Summit Therapeutics Provides Update on Ri-CoDIFy Trials. Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Based on a thorough …

Category: Contact NumberShow more

Summit Therapeutics Number of Employees 20152021 SMMT

6 hours ago Macrotrends.net Show details

Summit Therapeutics number of employees from 2015 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

SMMT Stock Price Summit Therapeutics Inc. Stock Quote (U

8 hours ago Marketwatch.com Show details

Summit Therapeutics stock price target cut to $4 from $22 at SunTrust RH. Jun. 28, 2018 at 7:51 a.m. ET by Tomi Kilgore.

Category: Contact NumberShow more

Summit Therapeutics Reports Financial Results and

9 hours ago Globenewswire.com Show details

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021. Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit

Category: Contact NumberShow more

Kintara Therapeutics to Present at the Q4 Investor Summit

5 hours ago Wfmz.com Show details

SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announces today that

Category: Contact NumberShow more

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS Encourages …

4 hours ago Finance.yahoo.com Show details

SAN FRANCISCO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ: RVNC) investors to with significant losses to submit your losses now. Visit: www.hbsslaw

Category: Contact NumberShow more

Sarepta Therapeutics and Summit Enter Into Exclusive

1 hours ago Globenewswire.com Show details

617-274-4052Sarepta Ian Estepan: Tel: 617-274-4052 [email protected] W2O Group Brian Reid: Tel: 212-257-6725 [email protected]

Category: Contact NumberShow more

Inhibikase Therapeutics to Participate in Upcoming Michael

9 hours ago Ih.advfn.com Show details

ATLANTA and BOSTON, Oct. 27, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders, today announced that Dr. Milton Werner, Ph.D., President & Chief Executive Officer of Inhibikase, will participate in the Michael J. Fox Foundation …

Category: Contact NumberShow more

What Type Of Shareholders Own The Most Number of CymaBay

9 hours ago Finance.yahoo.com Show details

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. It looks like hedge funds own 20% of …

Category: Contact NumberShow more

Summit Therapeutics Announces Closing of $75 Million

8 hours ago Marketscreener.com Show details

Cambridge, MA, May 12, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today the successful closing of its fully subscribed rights offering and the associated results.. The rights offering resulted in the sale of 14,312,976 shares of the Company’s common stock, par value $0.01 (the “Shares,” and each, a “Share”) at a price of $5.24 per Share.

Category: Contact NumberShow more

Seelos Therapeutics Presents a Poster on SLS002

6 hours ago Ih.advfn.com Show details

NEW YORK, Oct. 25, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today presented a poster on Part 1, the open-label portion, of the study of SLS-002 (Intranasal Racemic Ketamine) at the IASR/AFSP International Summit on Suicide …

Category: Contact NumberShow more

Inhibikase Therapeutics to Participate in Upcoming Michael

5 hours ago Wfmz.com Show details

ATLANTA and BOSTON, Oct. 27, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to …

Category: Contact NumberShow more

Home mRNABased Therapeutics Summit Europe

2 hours ago Mrnabased-therapeutics-europe.com Show details

Welcome to the mRNA- Based Therapeutics Summit Europe: Expanding the Therapeutic Applicability of mRNA- Based Drugs. Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders from Europe and the rest of the world to delve deep into the challenges associated with successfully designing and developing the next-generation of mRNA-based

Category: Home PhoneShow more

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB

3 hours ago Benzinga.com Show details

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) announced that it has completed dosing of 100 subjects for the Phase 1 portion of the ARCT-154 …

Category: Tech SupportShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is Summit Therapeutics plc?

Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics.

What is the overriding objective of Summit Therapeutics?

The overriding objective of Summit Therapeutics is to create value for patients, hospital caregivers, and community-based healthcare providers, as well as healthcare payers around the world.

How to apply for a job at Summit?

The following positions are open at Summit. To apply, please click the link for the position in which you’re interested below. We offer a competitive remuneration and benefits package. Trademarks, registered or otherwise, are the property of their respective owner (s). Website Designed and Developed by Carr Kamasa Design

Popular Brands

Sharp
Shell
Sap
Sgs
Sabb
Sea